Predaxa is a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem.
However, at least 21 Pradaxa lawsuits arising from incidences of abnormal bleeding are pending in a new legal action and attorneys expect that hundreds of additional lawsuits will be filed.
All of these claims allege common claims against Boehringer, including:
- Pradaxa caused uncontrollable and excessive bleeding;
- Boehringer failed to warn the medical community and consumers that there is no reversal agent to stop excessive Pradaxa bleeding should it occur;
- The lack of a Pradaxa reversal agent caused life threatening conditions, permanent disability and deaths;
- Pradaxa advertisements exaggerated the effectiveness of the drug with respect to preventing stroke and blood clots;
- Pradaxa was not properly researched before being approved; and
- Boehringer failed to adequately warn consumers about the serious complications of the drug, including severe bleeding.
Pradaxa has been linked to hundreds of deaths and, according to the Institute for Safe Medication Practices, caused more deaths than any other medication in 2011.
If you or someone you know has been taking Pradaxa and have experienced any of the symptoms and complications noted above, please call Florin Roebig for a free consultation at (727) 786-5000 or submit information about your case for an evaluation on our Contact page.